Entity

Time filter

Source Type


Wang X.,Center for Non Traumatic Treatment and Diagnosis of Tumors | Wang Y.-Y.,Center for Non Traumatic Treatment and Diagnosis of Tumors | Jiang P.,Center for Non Traumatic Treatment and Diagnosis of Tumors | Ma J.-J.,Center for Non Traumatic Treatment and Diagnosis of Tumors | And 4 more authors.
Experimental and Therapeutic Medicine | Year: 2012

The objective of the present study was to evaluate the application potential of CyberKnife for high-risk tumors of the central nervous system and to analyze the effectiveness of CyberKnife in relation to dose recovery and gain division (times). A total of Eighty-one targeted areas from 139 central nervous tumor lesions in 60 patients were treated with I-VI ranged CyberKnife for 1 week. Following CyberKnife treatment, imaging tests revealed a decrease in tumor volume, reduction of central nervous system symptoms and an increase in the life quality of patients. The advantages of CyberKnife include non-invasiveness, individualized treatment, flexibility, high accuracy and rapid treatment. CyberKnife produces slight damage and a favorable therapeutic effect and expands our concepts concerning precise radiotherapy for tumors. It is an indispensable method for personalized tumor treatment. Source

Discover hidden collaborations